Hodgkin Lymphoma in Adults

Hodgkin lymphoma, a type of cancer that starts in the lymphatic system, is one of the most curable forms of cancer. Our hematologist–oncologists, radiation oncologists, and radiologists offer personalized treatment plans to help people achieve remission, in which no cancer cells can be detected. Treatment approaches may include chemotherapy, radiation therapy, and rarely, stem cell transplantation. Our compassionate doctors and support staff ensure you have the psychological support you need throughout treatment and beyond.

Clinical Trials and Research Studies

Phase 1/2

AN OPEN-LABEL MULTICENTER PHASE l/1B TRIAL EVALUATING THE SAFETY ANDPHARMACOKINETICS OF ESCALATING DOSES OF BTCT4465A AS A SINGLE AGENT ANDCOMBINED WITH ATEZOLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORYB-CELL NON-HODGKIN S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA

Phase 1/2

A Phase I/IIa Study of BMS-986205 Administered in Combination with Nivolumab (BMS-935558 anti-PD-1 Monoclonal Antibody) in Advanced Malignant Tumors

Phase 2

Phase II Multi-center Trial of Nivolumab and Brentuximab Vedotin in Patients wit Untreated Hodgkin Lymphoma Over the Age of 60 Years or Unable to Receive Standard Adriamycin Bleomysin Vinblastine and Dacarbazin (ABVD) Chemotherapy

Phase 1

Phase I Study of MK-3475 (Pembrolizumab) in Patients with Human Immunodeficiency Virus (HIV) and Relapsed/Refractory or Disseminated Malignant Neoplasm